Emergent BioSolutions-Emergent Biosolutions (EBS) Q3 Earnings Beat Estimates

Emergent Biosolutions (EBS) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of$ 0.49 per share. This compares to loss of $1.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 179.59%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.97 per share when it actually produced a loss of $2.32, delivering a surprise of -139.18%.Over the last four quar ...